Adamed Pharma S.A. (manufacturing, primary and secondary packaging, batch control and batch release)

Ukraine

All drugs from this manufacturer

  • ADEL® C

    The drug is indicated for the treatment of men with symptoms of benign prostatic hyperplasia. It helps with frequent or urgent urges to urinate, as well as difficulties with the bladder emptying process itself.

    Dosage form: tablets, modified release

    Active substance Dosage
    solifenacin 4.5 mg
    tamsulosin 0.37 mg

    ATC: G04CA53